Literature DB >> 20665198

Interactions between lipid A and serum proteins.

Jörg Andrä1, Thomas Gutsmann, Mareike Müller, Andra B Schromm.   

Abstract

Entry of endotoxin (lipopolysaccharide (LPS) or lipid A) into the blood stream is causative for the emergence of sepsis and septic shock with all its pathophysiological consequences.(1) Serum contains a whole variety of proteins that interact with endotoxin. As large as the number of different proteins interacting with endotoxin, as broad are the consequences of these interactions. Serum proteins can either enhance cell activation by endotoxin or attenuate the cellular response, they can detoxify and eliminate endotoxin from the blood stream. In this chapter we summarize work on the investigation of the interaction of endotoxins with serum proteins. In four paragraphs we focus on proteins involved in the endotoxin-induced immune cell activation, detection by immunoglobulins, the transport of endotoxins and on proteins and peptides with the capability to neutralize the biological effects of endotoxin. There is a multitude of studies analyzing the interactions between serum proteins and endotoxins, however, with great differences in the source and quality of the endotoxins used. The number of studies dealing with chemically well defined endotoxin structures are quite limited. In addition, though lipid A is the biologically active entity, the "endotoxic principle", of LPS, the majority of studies was performed with LPS. Therefore, to be comprehensive, we included also studies dealing with LPS and not with lipid A if fundamental scientific problems were addressed. In that cases, we have to be aware that there may be differences in the protein interactions of lipid A and LPS, and we tried to emphasize this point in the respective paragraphs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20665198     DOI: 10.1007/978-1-4419-1603-7_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Polymyxin B protects against hepatic ischemia/reperfusion injury in a rat model of obstructive jaundice.

Authors:  Feng Xu; Chao-Liu Dai; Song-Lin Peng; Yang Zhao; Chang-Jun Jia; Yong-Qing Xu; Chuang Zhao
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

2.  Effect of solar particle event radiation and hindlimb suspension on gastrointestinal tract bacterial translocation and immune activation.

Authors:  Yu Zhou; Houping Ni; Minghong Li; Jenine K Sanzari; Eric S Diffenderfer; Liyong Lin; Ann R Kennedy; Drew Weissman
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

3.  Annexin A5 binds to lipopolysaccharide and reduces its endotoxin activity.

Authors:  Jacob H Rand; Xiao-Xuan Wu; Elaine Y Lin; Alexander Griffel; Philip Gialanella; John C McKitrick
Journal:  mBio       Date:  2012-03-13       Impact factor: 7.867

Review 4.  Towards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnect.

Authors:  James C Hurley
Journal:  Toxins (Basel)       Date:  2013-12-18       Impact factor: 4.546

Review 5.  Recent Advances in Lipopolysaccharide Recognition Systems.

Authors:  Lalita Mazgaeen; Prajwal Gurung
Journal:  Int J Mol Sci       Date:  2020-01-07       Impact factor: 5.923

6.  The lipid-bound apolipoprotein A-I cysteine mutant (N74C) inhibits the activation of NF-κB, JNK and p38 in endotoxemic mice and RAW264.7 cells.

Authors:  Yunlong Wang; Shulai Lu; Xinde Li; Na Du; Yunbo Sun; Jinyan Xing; Xinting Pan; Baosheng Chen; Zhimin Miao
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

7.  Capture of lipopolysaccharide (endotoxin) by the blood clot: a comparative study.

Authors:  Margaret T Armstrong; Frederick R Rickles; Peter B Armstrong
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.